Study on in vitro effects and mechanism of Thalidomide on prostate cancer cell line PC-3

Xuhui Cui,Xueyi Xue,Ning Xu

DOI: https://doi.org/10.3969/j.issn.1008-0848.2012.04.004

2012-01-01

Abstract:Objective To investigate the growing inhibitory effect of Thalidomide on hormone-independent prostatic cancer cell line PC-3, and explore the related mechanism. Methods PC-3 cells were treated with Thalidomide in different concentrations. The cell growth and proliferation were assessed by CCK-8 assay and the flow cytometry (FCM) was employed to examine the apoptosis rate. The level of HIF-1α and VEGF mRNA expression was examined by the RT-PCR technique in the PC-3 cells treated before and after with Thalidomide. The expression of HIF-1α,VEGF, Bcl-2 and Bax protein in PC-3 cells treated by Thalidomide was detected by the Western blot. Results With administration of Thalidomide in different concentrations, the growth and proliferation of PC-3 cells significantly decreased(P<0.05). Thalidomide produced antiproliferative effeets on PC-3 cells in a dose and time-dependent manner. The outcome of FCM indicated Thalidomide could induce apoptosis of PC-3 cells, and there was statistically significant difference between the control group and treatment group (P<0.05). The mRNA expression of HIF-1α and VEGF was gradually down-regulated with the increase of Thalidomide dosage. The Bax positivity of PC-3 cells treated with Thalidomide was increasing along with the increase of drug concentration, but not in the control cells. The HIF-1 α, VEGF and Bcl-2 content in PC-3 cells was lowering when Thalidomide was given in an increasing concentration. Conclusion Under the condition used in this study, Thalidomide can inhibit the proliferation of PC-3 cells in vitro. Induction of apoptosis and inhibition of angiogenesis may be possibly the two mechanisms for its anticancer action.